Skip to main content

Innosuisse — Portfolio, Page 8

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

213
Companies
$462.1M
Total invested
$2.8M
Avg. check
41
Industries
Biotechnology 12Health Care 10Medical 9Manufacturing 5Artificial Intelligence (AI) 4Medical Device 4+35 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 169192 of 213
Akina
January 2025

Akina provides AI-enabled connected therapy for patients with musculoskeletal conditions.

Health Care · Zürich$3.2M Seed
Capt'n Greenfin
January 2025

Capt'n Greenfin is a new material for sustainable fishing baits and aims to revolutionize the sportfishing industry in a sustainable way.

Manufacturing · BernSeed
Vestir AI
November 2024

Vestir AI is a retail tech company that offers a platform for online clothes shopping through AI-powered digital avatar technology.

Artificial Intelligence (AI) · Zug$535K Grant
Ymmunobio
November 2024

Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.

Biotechnology · BaselGrant
Vatorex
October 2024

Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite.

AgTech · WinterthurGrant
Picterra
October 2024

Geospatial ML SaaS platform for Earth Observation imagery

Aerospace · EcublensGrant
Bionomous
September 2024

Bionomous automates the screening, sorting, and plating of miniature biological entities to accelerating science

Biotechnology · Villaz-saint-pierre$3.5M Debt Financing
Vandria
August 2024

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

Manufacturing · Lausanne$10.1M Series A
Aspivix
June 2024

ASPIVIX is developing a device that makes gynecological procedures more comfortable for patients.

Biotechnology · Renens$556K Debt Financing
Topadur Pharma
June 2024

Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.

Biotechnology · Schlieren$3.4M Series Unknown
GaitQ
April 2024

gaitQ® develops innovative wearable technology that improves people’s mobility and quality of life.

Health Care · OxfordGrant
LEDCity
April 2024

LEDCity is a energy technology company that designs and develops efficient lighting systems for commercial buildings.

CleanTech · Zürich$2.2M Series Unknown
Spirecut
March 2024

Spirecut is a medtech company that democratizes minimally invasive surgery with ultrasound guided instruments

Manufacturing · Muttenz$800K Series A
Volumina Medical
March 2024

Volumina Medical is a healthcare technology company that engages develops injectable 3D scaffolds for the reconstruction of soft tissues.

Biotechnology · Epalinges$21.0M Series A
Hemotune
March 2024

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Biotechnology · Schlieren$15.6M Series B
Terapet
March 2024

Geneva-based MedTech spin-off from CERN, specializing in the development and manufacturing of innovative nuclear imaging systems.

Health Care · Geneva$1.8M Grant
FimmCyte
February 2024

FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.

Biotechnology · Basel$1.1M Convertible Note
Galventa
December 2023

Galventa provides pharmaceutical manufacturing services for a micro-pellet-based food supplement that relieves sleep inertia symptoms.

Biotechnology · Saint Gallen$1.8M Seed
Scailyte
December 2023

True precision medicine through single-cell science

Artificial Intelligence (AI) · Basel$1.8M Series A
GRZ Technologies
November 2023

GRZ Technologies is a company active in the field of renewable energy storage.

Renewable Energy · SionSeries Unknown
MPC Therapeutics
November 2023

MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.

Biotechnology · Plan-les-ouates$113K Debt Financing
Ascento
October 2023

Ascento designs a compact wheeled jumping robot for enhanced security in various environments.

Computer Vision · Zürich$168K Grant
TissueLabs
October 2023

TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.

3D Printing · Bellinzona$800K Seed
Atinary
September 2023

Atinary is an end-to-end AI, machine learning, robotics, and cloud computing technology platform for digitizing R&D operations.

Artificial Intelligence (AI) · Lausanne$5.0M Seed

Where Innosuisse invests

Biotechnology12
Health Care10
Medical9
Manufacturing5
Artificial Intelligence (AI)4
Medical Device4

About Innosuisse's portfolio

How many companies has Innosuisse invested in?

Innosuisse has invested in 213 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Innosuisse invest in?

Innosuisse's top investment sectors include Biotechnology, Health Care, Medical, Manufacturing, Artificial Intelligence (AI). The firm invests across 41 different industry categories.

What is Innosuisse's largest investment?

Among tracked funding rounds, Volumina Medical received $21.0M in a Series A round. Innosuisse's total known invested capital is $462.1M.

What is the average investment size for Innosuisse?

Innosuisse's average investment size is $2.8M across its portfolio of 213 companies.

What are Innosuisse's most recent investments?

Recent Innosuisse portfolio additions include Akina, Capt'n Greenfin, Vestir AI, Ymmunobio, Vatorex. These companies were founded in 2020 or later.

Reach the founders behind these 213 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →